Latest From Biotech Now

Latest One-Sided CNBC Interview Repeats Falsehoods, Offers Misleading Statistics

new-bio-logo

I was disappointed by CNBC’s one-sided reporting in an article that repeated numerous falsehoods and misleading statistics that have been previously debunked, apparently based on a single interview with Dr. Kenneth Davis, the President and CEO of Mount Sinai Medical. Unfortunately, this is nothing new. The insurance industry and its allies continue to use the biopharmaceutical industry as a scapegoat for their ever-increasing insurance premiums, deductibles, and co-pays. It’s time to set the record straight. Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Principles Put Patients First

Greenwood_Jim_BTN

Patient advocacy organizations play an indispensable role in the biopharmaceutical development process: They help scientists and researchers better understand what it’s like to live with the diseases they’re trying to cure. That’s why BIO and our member companies are deeply committed to meaningful partnerships with patient advocacy organizations as we work to discover new medications to help patients live longer, healthier, more fulfilling lives. Today, there are more than 250 biotechnology health care medications and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Challenging Entrepreneurs to Heal the World

shutterstock_26191726

The healthcare industry needs a refresh! Through improvements in medicine, sanitation and general living conditions, we’ve made great strides at fighting many of the maladies that have plagued humanity for centuries, lowering child mortality rates while increasing life spans by decades. Yet as a consequence of living longer, we’re facing new health issues and the increasing prevalence of chronic conditions and , neurodegenerative,  metabolic and immunological diseases. Despite scientific advancements in many fields, insufficient progress Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Trust the Science, Not the Food Fad

GMO Answers

Multiple surveys and polls reveal most people know very little about GMOs, causing them to buy into expensive food fads. We’ve published a piece on the GMO Answers Forbes blog by Robert Wager, from Vancouver Island University, and Terry Daynard, farmer and former associate dean at University of Guelph, entitled, “GMOs: Trust The Science, Not The Food Fad.” Instead of focusing on what’s on the label, Robert and Terry urge consumers to understand what they Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,